Phase Ib Study to Determine MTD of AZD1775 Monotherapy in Patients with Locally Advanced or Metastatic Solid Tumours.

Trial Identifier: D6015C00003
Sponsor: AstraZeneca
NCTID:: NCT02610075
Start Date: December 2015
Primary Completion Date: April 2018
Condition: Cancer - Other; Ovarian Cancer

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description
English Translation

Trial Locations

Country Location
United States of America, AZ Scottsdale, AZ, United States of America, 85258
United States of America, CO Denver, CO, United States of America, 80218
United States of America, TN Nashville, TN, United States of America, 32705